NCT00829998View on ClinicalTrials.gov

Zaleplon 10mg Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Healthy
Interventions
DRUG

Zaleplon 10 mg Capsules

1 x 10 mg, single-dose fasting

DRUG

Sonata® 10 mg Capsules

1 x 10 mg, single-dose fasting

Trial Locations (1)

77040

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00829998 - Zaleplon 10mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter